Non-Invasive Prenatal Testing (NIPT) Market is estimated to be 11.8 Billion by 2029 with a CAGR of 11.9% during the forecasted period.
%20Market.gif)
A Non-Invasive Prenatal Testing (NIPT) is a screening test to identify if the unborn child/fetus is at risk for a number of genetic disorders like Down syndrome, Edwards syndrome, Patau syndrome, etc. The test is done by using blood sample thus reducing the risk of miscarriage during testing to absolute nil coupled with the ability to screen for a number of disorders within 10 weeks in pregnancy, much earlier as compared to any other prenatal diagnostic tests. NIPT has been ranked as the most successful, sensitive and the most accurate test thereby being the mostly preferred test. The global non-invasive prenatal testing (NIPT) market accounted for US$ 4.3 billion in 2019 and is estimated to be US$ 11.8 billion by 2029 and is anticipated to register a CAGR of 11.9%. The report " Global Non-Invasive Prenatal Testing (NIPT) Market, By Product Type (Devices, Consumables, and Others), By Techniques (cfDNA, Biochemical Screening Tests, and Ultrasound Detection), By App...